1668-10-6 H-Gly-NH2.HCl

Glycinamide hydrochloride is an important raw material for the preparation of the new central nervous system drug Oracetam, which has the properties of activating, protecting and promoting the functional recovery of damaged nerve cells, and is clinically used for the treatment of mild to moderate vascular dementia, Alzheimer's disease, as well as memory and intelligence disorders caused by traumatic brain injury and other disorders. In addition, Glycinamide HCL can be used as a substitute for sodium chloride, which can increase the salty flavour of food and reduce the intake of sodium chloride, which can prevent the excessive intake of sodium ions and cause hypertension and other diseases such as kidney, which is an important salt. The product is cyclised with glyoxal to obtain 2-hydroxypyrazine, which is then chlorinated with trichlorophosphorus to produce 2,3-dichloropyrazine, which is used in the production of the sulphonamide SMPZ.